CD274 and preeclampsia: Furthermore, the aberrant differentiation of Tregs can be rectified by the PD-1/PD-L1 activator PD-L1 Fc, which indicates a potential therapeutic value of the PD-1/PD-L1 pathway for patients with preeclampsia (59).